Heritas Capital Management is proud to announce that it has been appointed as a co-investment partner with SPRING SEEDS Capital (SSC), the investment arm of SPRING Singapore, under the Startup SG Equity scheme. Startup SG Equity is an initiative under Startup SG, which offers a holistic range of support...
Strand Life Sciences announced an investment by Quadria Capital, Asia’s leading healthcare focused private equity investor. India-based HealthQuad Fund and Singapore-based Heritas Venture Fund also contributed to this fund. Strand Life Sciences, formed from the business combination of Strand and Triesta, the diagnostics unit of HCG, is India’s leading specialized...
Heritas Capital Management is pleased to complete its investment in Tessa Therapeutics (“Tessa”), an international clinical stage biopharmaceutical company focusing on T cell therapy for solid tumours. Tessa’s Virus-Specific T cell (“VST”) technology has demonstrated compelling results in the treatment of solid tumours. The company is currently conducting a multi-center...
